RyboDyn
Chemicals & Related Products · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10935 Alexandria Way Ste 204, San Diego,...Website
www.rybodyn.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RyboDyn
Rybo Dynamics is dedicated to advancing scientific breakthroughs for laboratories worldwide to develop innovative medicines that promote a healthier future for everyone. By unlocking the potential of the dark proteome, Rybo Dynamics aims to provide targeted therapeutics for a better quality of life.Explore more
RyboDyn Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RyboDyn your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at RyboDyn
Click to see if RyboDyn had a recent Job posting/layoffs
Product Launch: Get notified when RyboDyn launches new products
Check out if RyboDyn is spiking on competitors!
RyboDyn, which may be a good buyer, showed buying intent in Masked Content Topic
Check if RyboDyn has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RyboDyn has new funding data
Earning: See what the market has to say on RyboDyn recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to RyboDyn
Compare insights from companies similar to RyboDyn, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RyboDyn is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RyboDyn is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RyboDyn.
RyboDyn financials insights
Gather financial insights about RyboDyn, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$4M
2026
Seed
$10M
RyboDyn Tech Stack
A closer look at the technologies used by RyboDyn
Most Recent Scoops
Funding
Funding
Partnership
Project
Partnership, Product Development, Research & Development, Business Development, Medical Research, Pharmaceuticals
Funding
Funding
Funding
RyboDyn News & Media
RYBODYN ANNOUNCES SEED FINANCING TO ADVANCE AI-DRIVEN DISCOVERY OF HIDDEN CANCER TARGETS
Company's CypherAtlas™ database emerges as one of oncology's largest integrated dark transcriptome and proteome resources SAN DIEGO, March 24, 2026 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company decoding the dark proteome using an AI-powered novel sequencing and discovery...RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome
Lilly Collaboration Accelerates RyboDyn's Dark Proteome Targets Toward First-in-Class Therapies SAN DIEGO, June 19, 2025 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, today announced its selection to join...RyboDyn Expands Strategic Cancer Immunotherapy Collaboration with Moffitt Cancer Center
Dark genome biotech RyboDyn deepens partnership with world-leading cancer immunotherapy center to validate novel oncology targets and advance first-in-class therapies SAN DIEGO, May 15, 2025 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies...RyboDyn: $4 Million (Pre-Seed) Raised To Pioneer Development Of First-In-Class Immunotherapies
RyboDyn announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round to advance its mission of targeting the dark proteome to develop novel immunotherapies. The funding round was co-led by Genedant Capital and SeaX Ventures, with significant participation from SOSV and Swell VC as part of the investment syndicate.
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RyboDyn
Sign Up For FreeTo access detailed company insights
Rybo Dynamics is dedicated to advancing scientific breakthroughs for laboratories worldwide to develop innovative medicines that promote a healthier future for everyone. By unlocking the potential of the dark proteome, Rybo Dynamics aims to provide targeted therapeutics for a better quality of life.... Read More
